The United States Food and Drug Administration (USFDA) has inspected one of the Manufacturing facilities of Neuland Laboratories (Unit 2), located at Pashmylaram, Patancheru Mandal, Sangareddy District, from February 3-7, 2020.
The inspection has been completed with two observations given under form 483, which are procedural in nature. The company has already initiated corrective and preventive actions for the observations and is confident of satisfying the FDA within the stipulated time.
Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.
